1. Home
  2. PDLB vs STRO Comparison

PDLB vs STRO Comparison

Compare PDLB & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDLB
  • STRO
  • Stock Information
  • Founded
  • PDLB 1960
  • STRO 2003
  • Country
  • PDLB United States
  • STRO United States
  • Employees
  • PDLB N/A
  • STRO N/A
  • Industry
  • PDLB
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PDLB
  • STRO Health Care
  • Exchange
  • PDLB Nasdaq
  • STRO Nasdaq
  • Market Cap
  • PDLB 297.5M
  • STRO 172.8M
  • IPO Year
  • PDLB 2017
  • STRO 2018
  • Fundamental
  • Price
  • PDLB $12.75
  • STRO $1.97
  • Analyst Decision
  • PDLB
  • STRO Strong Buy
  • Analyst Count
  • PDLB 0
  • STRO 7
  • Target Price
  • PDLB N/A
  • STRO $12.14
  • AVG Volume (30 Days)
  • PDLB 45.0K
  • STRO 1.4M
  • Earning Date
  • PDLB 01-28-2025
  • STRO 11-13-2024
  • Dividend Yield
  • PDLB N/A
  • STRO N/A
  • EPS Growth
  • PDLB N/A
  • STRO N/A
  • EPS
  • PDLB 0.37
  • STRO N/A
  • Revenue
  • PDLB $79,488,000.00
  • STRO $160,955,000.00
  • Revenue This Year
  • PDLB N/A
  • STRO N/A
  • Revenue Next Year
  • PDLB $11.39
  • STRO N/A
  • P/E Ratio
  • PDLB $34.76
  • STRO N/A
  • Revenue Growth
  • PDLB 33.32
  • STRO 230.90
  • 52 Week Low
  • PDLB $7.89
  • STRO $1.70
  • 52 Week High
  • PDLB $13.43
  • STRO $6.13
  • Technical
  • Relative Strength Index (RSI)
  • PDLB 50.79
  • STRO 31.89
  • Support Level
  • PDLB $12.15
  • STRO $1.70
  • Resistance Level
  • PDLB $13.36
  • STRO $3.01
  • Average True Range (ATR)
  • PDLB 0.32
  • STRO 0.20
  • MACD
  • PDLB -0.10
  • STRO -0.01
  • Stochastic Oscillator
  • PDLB 46.88
  • STRO 20.61

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

Share on Social Networks: